Efficacy of bleomycin and sirolimus in inhibiting CD31+ endothelial cell proliferation in noninvoluting congenital hemangiomas
ObjectiveCongenital hemangiomas are rare vascular anomalies that manifest at birth. Noninvoluting congenital hemangiomas present significant clinical challenges due to their persistence and associated complications. The mechanisms underlying congenital hemangiomas remain poorly understood, and curre...
Saved in:
| Main Authors: | Yanan Li, Chuan Wang, Yi Li, Xinglong Zhu, Ji Bao, Yi Ji |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-08-01
|
| Series: | Frontiers in Cell and Developmental Biology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fcell.2025.1629770/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effectiveness and safety of topical sirolimus in children with angiofibromas and tuberous sclerosis complex
by: Andrea Fernández de Lara-Arrieta, et al.
Published: (2025-04-01) -
Prospective study of safety, immunogenicity, and efficacy of inactivated COVID-19 vaccine in tuberous sclerosis complex children on sirolimus
by: Sufang Lin, et al.
Published: (2025-12-01) -
Hemangioma hepático congénito gigante: síndrome de Kasabach-Merrit
by: Carlos Cortes Caballero, et al.
Published: (2018-10-01) -
Recurrent cavernous orbitocranial hemangioma. A clinical case and a literature review
by: N. K. Serova, et al.
Published: (2022-09-01) -
Capillary and Cavernous (Mixed) Type of Cervical Hemangioma with Uterine Adenomyosis in a 40-year-old Female
by: Shweta S Joshi, et al.
Published: (2025-08-01)